Searched over 200M research papers for "cholesterol ratio"
10 papers analyzed
These studies suggest that the total cholesterol/HDL ratio is a significant predictor of coronary heart disease risk and can guide lipid modification strategies, though its clinical use is debated.
20 papers analyzed
The total cholesterol to high-density lipoprotein cholesterol (TC/HDL-C) ratio is a significant marker for assessing cardiovascular risk. This ratio provides additional information beyond traditional lipid measures like low-density lipoprotein cholesterol (LDL-C) and non-HDL cholesterol. Studies have shown that the TC/HDL-C ratio can reclassify atheroma progression and major adverse cardiovascular events (MACE) rates, especially when discordant with LDL-C, non-HDL-C, and apolipoprotein B (apoB) levels . For instance, patients with lower LDL-C but higher TC/HDL-C ratios exhibited less regression in atheroma volume and higher MACE rates, indicating the importance of considering this ratio in clinical assessments.
National and international trends reveal significant variations in cholesterol ratios. In a comprehensive analysis of 458 population-based studies, it was found that while total cholesterol (TC) levels have increased in Asian countries, this rise is attributed to different factors. In Japan and South Korea, the increase in TC is due to rising HDL cholesterol, whereas in China, it is due to rising non-HDL cholesterol. Conversely, in Western countries, TC levels have generally declined, driven by an increase in HDL cholesterol and a decrease in non-HDL cholesterol. This has led to a decline in the TC/HDL-C ratio, which correlates with a reduced risk of coronary heart disease.
The distribution of TC/HDL-C ratios varies significantly across different demographic and socioeconomic groups. Data from the NHANES II study indicate that men generally have higher TC/HDL-C ratios compared to women, and Whites have higher ratios compared to Blacks. Factors such as age, body mass index (BMI), smoking, and physical activity levels also influence these ratios. For example, higher BMI and smoking are associated with higher TC/HDL-C ratios, while physical activity and alcohol use are associated with lower ratios.
Genetic factors also play a role in determining cholesterol ratios. Research within a Korean population identified six single nucleotide polymorphisms (SNPs) that can predict TC/HDL-C and triglyceride (TG)/HDL-C ratios. These genetic markers can help in understanding individual variations in lipid metabolism and the risk of cholesterol-related diseases.
Discordance between TC/HDL-C ratios and other lipid measures like LDL-C and non-HDL cholesterol can provide critical insights into cardiovascular risk. In the ARIC study, individuals with lower LDL-C but higher TC/HDL-C ratios had a significantly higher risk of atherosclerotic cardiovascular disease. This discordance was particularly prevalent among individuals with diabetes, highlighting the need for comprehensive lipid profiling in risk assessment.
Longitudinal studies have shown that lifestyle factors and pharmacologic treatments significantly impact cholesterol ratios over time. For instance, maintaining an ideal weight, regular physical activity, and treatment for hyperlipidemia are associated with favorable changes in the TC/HDL-C ratio. Conversely, weight gain and physical inactivity are linked to higher ratios, underscoring the importance of healthy lifestyle choices in managing cardiovascular risk.
The TC/HDL-C ratio is a valuable tool in assessing cardiovascular risk, offering insights beyond traditional lipid measures. Understanding the demographic, genetic, and lifestyle factors that influence this ratio can help in developing targeted interventions to reduce the risk of coronary heart disease. Regular monitoring and comprehensive lipid profiling, including the TC/HDL-C ratio, are essential for effective cardiovascular risk management.
Most relevant research papers on this topic